![]() |
VX-702
- 英文名称:VX-702
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10580
- cas:745833-23-2
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10580 |
用途 | 科研检测 |
英文名称 | VX-702 |
包装规格 | 1MG |
CAS编号 | 745833-23-2 |
别名 | VX-702 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C19H12F4N4O2
分子量:404.32
溶剂:DMSO (40 mg/ml) Ethanol (2 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):p38α MAP kinase inhibitor
Function / Pharmacology:A potent and selective inhibitor of p38 MAP kinases, p38? MAPK and p38? (KD = 3.7 and 17 nM respectively).1 Inhibits IL-6, IL-1? and TNF? production in LPS-primed blood.1 Inhibits p38 in platelets stimulated by thrombin, collagen or thromboxane agonist U-46619 at 1 ?M.2 Provides only modest clinical efficacy in rheumatoid arthritis.3,4 Delays platelet lesions and leads to better maintenance of stored platelets.5
分子式:C19H12F4N4O2
分子量:404.32
溶剂:DMSO (40 mg/ml) Ethanol (2 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):p38α MAP kinase inhibitor
Function / Pharmacology:A potent and selective inhibitor of p38 MAP kinases, p38? MAPK and p38? (KD = 3.7 and 17 nM respectively).1 Inhibits IL-6, IL-1? and TNF? production in LPS-primed blood.1 Inhibits p38 in platelets stimulated by thrombin, collagen or thromboxane agonist U-46619 at 1 ?M.2 Provides only modest clinical efficacy in rheumatoid arthritis.3,4 Delays platelet lesions and leads to better maintenance of stored platelets.5